Clinical Trials Logo

Diabetic Neuropathy, Painful clinical trials

View clinical trials related to Diabetic Neuropathy, Painful.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01063868 Terminated - Clinical trials for Diabetic Polyneuropathy

A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN)

Start date: January 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety profile of orally administered tapentadol ER dosages of 100 to 250 mg twice daily in patients with chronic, painful diabetic peripheral neuropathy (DPN) over long-term exposure of up to 1 year.

NCT ID: NCT01050218 Terminated - Clinical trials for Diabetic Neuropathy, Painful

Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral Neuropathy

Start date: July 2006
Phase: Phase 3
Study type: Interventional

The purpose of the study is to learn if long-term treatment with DVS SR is safe for treating the pain and other symptoms associated with diabetic peripheral neuropathy.

NCT ID: NCT00073034 Terminated - Diabetes Mellitus Clinical Trials

Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic Neuropathy

Start date: January 2004
Phase: Phase 2
Study type: Interventional

EAA-090 is being developed for the treatment of neuropathic pain associated with diabetic neuropathy. It is a selective antagonist that binds competitively to the glutamate site of the N-methyl-D-aspartate (NMDA) receptor. This study will assess the safety and efficacy of 3 fixed oral doses of EAA-090 compared with placebo in subjects with neuropathic pain associated with diabetic neuropathy.